223 related articles for article (PubMed ID: 27384061)
1. Pyoderma Gangrenosum, Acne and Suppurative Hidradenitis Syndrome Treated with Granulocyte and Monocyte Adsorption Apheresis.
Mizutani Y; Okano T; Takahashi T; Ohnishi H; Ohara O; Sano A; Seishima M
Acta Derm Venereol; 2017 Feb; 97(2):275-276. PubMed ID: 27384061
[No Abstract] [Full Text] [Related]
2. Successful treatment of pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome with granulocyte and monocyte adsorption apheresis.
Hatanaka M; Fujii K; Kanekura T
J Dermatol; 2021 Aug; 48(8):e376-e377. PubMed ID: 33991008
[No Abstract] [Full Text] [Related]
3. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
[TBL] [Abstract][Full Text] [Related]
4. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.
Fattore D; Pistone G; Bongiorno MR
G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847
[No Abstract] [Full Text] [Related]
5. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.
Murphy B; Morrison G; Podmore P
Int J Colorectal Dis; 2015 Aug; 30(8):1139-40. PubMed ID: 25564349
[No Abstract] [Full Text] [Related]
6. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
Russo I; Miotto S; Colpo A; Marson P; Tison T; Ferrazzi A; Alaibac M
Int Wound J; 2017 Feb; 14(1):282-284. PubMed ID: 27790848
[TBL] [Abstract][Full Text] [Related]
8. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
Bruzzese V
J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management.
Yan A; Gallardo M; Savu A; Kaffenberger B
Arch Dermatol Res; 2024 Jun; 316(7):397. PubMed ID: 38878169
[TBL] [Abstract][Full Text] [Related]
10. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy.
Koshelev MV; Garrison PA; Wright TS
Pediatr Dermatol; 2014; 31(1):e20-1. PubMed ID: 24118007
[TBL] [Abstract][Full Text] [Related]
11. Tumor Necrosis Factor Antagonists in the Treatment of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Syndrome.
Saint-Georges V; Peternel S; Kaštelan M; Brajac I
Acta Dermatovenerol Croat; 2018 Jun; 26(2):173-178. PubMed ID: 29989876
[TBL] [Abstract][Full Text] [Related]
12. PASH syndrome associated with osteopoikilosis.
Gracia-Cazaña T; Frias M; Roselló R; Vera-Álvarez J; Gilaberte Y
Int J Dermatol; 2015 Sep; 54(9):e369-71. PubMed ID: 26175185
[No Abstract] [Full Text] [Related]
13. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
Vinkel C; Thomsen SF
Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
[TBL] [Abstract][Full Text] [Related]
14. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
Shenefelt PD
Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum associated with ulcerative colitis: A recalcitrant case responded to adalimumab with granulocyte and monocyte adsorption apheresis.
Isami Y; Kawase Y; Kondo A; Akita W; Yasuda K; Matsutani T; Mitsui H
J Dermatol; 2020 May; 47(5):e213-e215. PubMed ID: 32162361
[No Abstract] [Full Text] [Related]
16. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome.
Calderón-Castrat X; Bancalari-Díaz D; Román-Curto C; Romo-Melgar A; Amorós-Cerdán D; Alcaraz-Mas LA; Fernández-López E; Cañueto J
Br J Dermatol; 2016 Jul; 175(1):194-8. PubMed ID: 26713508
[No Abstract] [Full Text] [Related]
17. Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
Satoh TK
J Dermatol; 2024 Feb; 51(2):160-171. PubMed ID: 38031879
[TBL] [Abstract][Full Text] [Related]
18. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis.
Kawakami T; Yamazaki M; Soma Y
Am J Gastroenterol; 2009 Sep; 104(9):2363-4. PubMed ID: 19727102
[No Abstract] [Full Text] [Related]
19. Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
Kanekura T; Kawahara K; Maruyama I; Kanzaki T
Ther Apher Dial; 2005 Aug; 9(4):292-6. PubMed ID: 16076369
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review.
Hsiao JL; Antaya RJ; Berger T; Maurer T; Shinkai K; Leslie KS
Arch Dermatol; 2010 Nov; 146(11):1265-70. PubMed ID: 21079064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
